P3-0314 — Annual report 2013
1.
Genetics, Human genome

The interview on TV SLO addressed the possibilities of using genetics and genome studies in patients with rheumatoid arthritis. The main themes were genetic analyses and their use in clinical practice. Genetic analyses could help in building prediction models, indicating how a patient will react to certain drugs. The event also emphasized potential genetic guidelines for the future.

D.11 Other

COBISS.SI-ID: 1487227
2.
PATENT DEVELOPMENT

Fluorimetric immune method of detecting anti-double stranded DNA antibodies

F.22 Improvement to existing health/diagnostic methods/procedures

3.
Scleroderma, Fibrosis and mechanism of pathology - FULBRIGHT SCHOLARSHIP from the American Government

In 2013/2014 one of our doctoral students is conducting research at Northwestern University, USA. She is involved in researching scleroderma, a severe autoimmune disease for which there is currently no cure. Her work includes determination of the role of adiponectin in the development of early fibrosis using in vivo and in vitro models, potencial biomarkers in patients with scleroderma and to research pharmacological strategies of fibrosis resolution.

E.02 International awards

4.
Detection of inflammatory marker Serum amyloid A (SAA) in autoimmune and other patients

The Laboratory of Immunology has introduced a new service, namely measuring the levels of SAA following nephelometric methodology

F.11 Development of a new service

5.
EU-MUSC European project/network concerned with musculoskeletal health

Summary Report (12 pages) Musculoskeletal Health in Europe EUMUSC.Net is an information and surveillance network of 22 institutions across 17 countries, supported by the European Community (EC Community Action in the Field of Health 2008-2013) and EULAR

D.06 Final report on a foreign/international project